Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.42 |
| ▸ | PGK1 | P00558 | 1/20 | 0.42 |
| ▸ | PGK2 | P07205 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25374097 | 0.83 | RAB9A (0.46) | CYP2C19HPGDPOLBTDP1TAAR1 | |
| SCHEMBL12651085 | 0.80 | TAAR1 (0.42) | CYP2C19HPGDPOLBTDP1TAAR1 | |
| SCHEMBL27406652 | 0.79 | TAAR1 (0.50) | CYP2C19HPGDPOLBTDP1TAAR1 | |
| SCHEMBL9656889 | 0.78 | CYP2C19 (0.56) | CYP2C19HPGDPOLBTDP1TAAR1 | |
| SCHEMBL6978499 | 0.77 | RAB9A (0.43) | CYP2C19HPGDPOLBTDP1RAB9A | |
| SCHEMBL8083549 | 0.75 | SRC (0.47) | CYP2C19HPGDPOLBTDP1RAB9A | |
| SCHEMBL2318487 | 0.75 | TAAR1 (0.50) | CYP2C19POLBTDP1TAAR1RAB9A | |
| SCHEMBL11549019 | 0.75 | HPGD (0.49) | CYP2C19HPGDPOLBTDP1RAB9A | |
| SCHEMBL22733890 | 0.74 | HPGD (0.51) | CYP2C19HPGDPOLBTDP1RAB9A | |
| SCHEMBL28158014 | 0.74 | POLB (0.45) | CYP2C19HPGDPOLBTDP1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119024654-A | Method for forming pattern | 三星SDI株式会社 | 2024-11-26 | — | — | CN | claimed |
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-01-31 | — | — | US | claimed |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| US-20240393684-A1 | METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2024-11-28 | — | — | US | disclosed |
| CN-119024654-A | Method for forming pattern | 三星SDI株式会社 | 2024-11-26 | — | — | CN | disclosed |
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
| US-10300155-B2 | Alpha-synuclein ligands | WASHINGTON UNIVERSITY (US) | 2019-05-28 | — | — | US | disclosed |
| US-20170189566-A1 | ALPHA-SYNUCLEIN LIGANDS | WASHINGTON UNIVERSITY (US) | 2017-07-06 | — | — | US | disclosed |
| US-9127020-B2 | Evaporable organic semiconductive material and use thereof in an optoelectronic component | HELIATEK GMBH (DE) | 2015-09-08 | — | — | US | disclosed |
| US-8846978-B2 | Electronic devices comprising novel phosphonic acid surface modifiers | IMPERIAL INNOVATIONS LTD. (GB) | 2014-09-30 | — | — | US | disclosed |
| US-20130167930-A1 | EVAPORABLE ORGANIC SEMICONDUCTIVE MATERIAL AND USE THEREOF IN AN OPTOELECTRONIC COMPONENT | HELIATEK GMBH (DE) | 2013-07-04 | — | — | US | disclosed |
| US-20120218681-A1 | SOLID ELECTROLYTIC CAPACITOR AND MANUFACTURING METHOD THEREOF | SANYO ELECTRIC CO., LTD. (JP) | 2012-08-30 | — | — | US | disclosed |
| EP-2483267-A1 | EVAPORABLE ORGANICALLY SEMICONDUCTIVE MATERIAL AND USE THEREOF IN AN OPTOELECTRONIC COMPONENT | Heliatek GmbH (DE) | 2012-08-08 | — | — | EP | disclosed |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | NATIONAL SCIENCE FOUNDATION | 2012-05-10 | — | — | US | disclosed |
| WO-2011161262-A1 | EVAPORABLE ORGANICALLY SEMICONDUCTIVE MATERIAL AND USE THEREOF IN AN OPTOELECTRONIC COMPONENT | HELIATEK GMBH (DE) | 2011-12-29 | — | — | WO | disclosed |
| US-20110188173-A1 | SOLID ELECTROLYTIC CAPACITOR AND MANUFACTURING METHOD THEREOF | SANYO ELECTRIC CO., LTD. (JP) | 2011-08-04 | — | — | US | disclosed |
| WO-2004065384-A1 | NONLINEAR OPTICAL COMPOUNDS AND METHODS FOR THEIR PREPARATION | UNIVERSITY OF WASHINGTON (US) | 2004-08-05 | — | — | WO | disclosed |
| WO-1993023039-A1 | SUBSTITUTED 4-AZA-5A-ANDROSTAN-ONES AS 5A-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| US-4233251-A | PARTIALLY CHLORINATED CYCLOPENTADIENE REACTED WITH CHLORINE IN THE PRESENCE OF A PHOSPHORUS COMPOUND | VELSICOL CHEMICAL CORPORATION (US) | 1980-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10300155-B2 | Alpha-synuclein ligands | SNCA, PARK7, LRRK2 | CYP2C19 4840/4885HPGD 3093/4885POLB 3070/4885 |
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | TST, SELENOI, SELE | CYP2C19 3198/4885HPGD 2574/4885POLB 2449/4885 |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | EFNA1, PHOSPHO1, EPHA6 | CYP2C19 3428/4885HPGD 4387/4885POLB 1610/4885 |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | TST, SELENOI, SELE | CYP2C19 3198/4885HPGD 2574/4885POLB 2449/4885 |
| US-20170189566-A1 | ALPHA-SYNUCLEIN LIGANDS | SNCA, PARK7, LRRK2 | CYP2C19 4840/4885HPGD 3093/4885POLB 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.